Stock Events

Stock Events

Matinas Biopharma (MTNB) Q4 2024 Earnings

13NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-1.25

-0.84

-0.44

-0.03

Details

Expected EPS

-1.055

Actual EPS

-0.85

Surprise EPS

0.2

Surprise Percent

+19.43%

Description

Matinas Biopharma (MTNB) has reported earnings of -0.85 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.